Otolaryngology research fellows have access to a wide range of collaborative resources and facilities at Mayo Clinic's Florida campus and across the enterprise.
TG4050 elicits strong polyepitopic, polyclonal, durable cytotoxic and effector neoantigen-specific CD8 T cell responses Results reinforce TG4050 ...
Researchers at the University of California San Diego have now developed a groundbreaking “one-click” AI tool that could ...
The FDA and European Medicines Agency (EMA) have awarded orphan drug designation to CPI-008 (cRGD-ZW800-1), a novel ...
A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune response in five preclinical models of head and neck cancer, according to ...
Head and neck cancer (HNC) is a prevalent malignant disease, ranking as the sixth most common cancer globally, with approximately 950,000 new cases and ...
Surgeons say a fluorescent agent could reduce nerve damage during complex procedures affecting speech and swallowing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback